Generate a comprehensive and actionable clinical summary paragraph for Patient eb1a19ea-3ca3-fa6b-70eb-fdd4787d6fbf Spencer878 Tobias236 male 1955-10-20 735 Becker Ferry Eliot ME 00000. Summarize in a one A4 page length report patient's medical history, treatment course, and include relevant clinical information, advice, and a clear course of action. Ensure the summary is concise yet informative, enabling doctors to effectively engage with the patient and guide their ongoing care given this data information: Condition Housing unsatisfactory (finding) Condition Received certificate of high school equivalency (finding) Condition Limited social contact (finding) Condition Stress (finding) Diagnosis Report History and physical note 1973-12-14 00:01:30+11:00 Condition Body mass index 30+ - obesity (finding) Condition Full-time employment (finding) Condition Stress (finding) Diagnosis Report History and physical note 1977-12-23 00:01:30+11:00 Condition Stress (finding) Diagnosis Report History and physical note 1987-01-02 00:01:30+11:00 Condition Ischemic heart disease (disorder) Condition Full-time employment (finding) Diagnosis Report History and physical note 1999-11-05 00:01:30+11:00 Condition Abnormal findings diagnostic imaging heart+coronary circulat (finding) Diagnosis Report History and physical note 1999-11-14 11:53:51+11:00 Condition History of coronary artery bypass grafting (situation) Diagnosis Report History and physical note 1999-12-04 18:08:56+11:00 Condition Stress (finding) Diagnosis Report History and physical note 2002-10-17 23:01:30+10:00 Condition Full-time employment (finding) Diagnosis Report History and physical note 2003-11-14 00:01:30+11:00 Condition Stress (finding) Diagnosis Report History and physical note 2006-10-26 23:01:30+10:00 Condition Stress (finding) Diagnosis Report History and physical note 2008-11-07 00:01:30+11:00 Condition Stress (finding) Diagnosis Report History and physical note 2011-11-25 00:01:30+11:00 Condition Medication review due (situation) Condition Reports of violence in the environment (finding) Condition Victim of intimate partner abuse (finding) Observation final Body Height 164.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} Observation final Body Weight 95.7 kg Observation final Body mass index (BMI) [Ratio] 35.45 kg/m2 Observation final Blood pressure panel with all children optional 64 mm[Hg] 112 mm[Hg] Observation final Heart rate 84 /min Observation final Respiratory rate 13 /min Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 0 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2013-12-06T00:01:30+11:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2013-12-06 01:10:35+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2013-12-06 01:47:29+11:00 Diagnosis Report History and physical note 2013-12-06 00:01:30+11:00 Condition Part-time employment (finding) Observation final Body Height 164.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 {score} Observation final Body Weight 95.7 kg Observation final Body mass index (BMI) [Ratio] 35.45 kg/m2 Observation final Blood pressure panel with all children optional 61 mm[Hg] 115 mm[Hg] Observation final Heart rate 71 /min Observation final Respiratory rate 12 /min Observation final Cholesterol [Mass/volume] in Serum or Plasma 150.64 mg/dL Observation final Triglycerides 114.46 mg/dL Observation final Low Density Lipoprotein Cholesterol 97.36 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 30.39 mg/dL Observation final Tobacco smoking status Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 2 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2014-12-12T00:01:30+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2014-12-12 00:01:30+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2014-12-12 01:16:24+11:00 Diagnosis Report History and physical note 2014-12-12 00:01:30+11:00 Diagnosis Report History and physical note 2015-10-28 01:08:27+11:00 Condition Streptococcal sore throat (disorder) Observation final Body temperature 39.119 Cel Diagnosis Report History and physical note 2015-10-24 03:01:30+11:00 Condition Hyperlipidemia Condition Unemployed (finding) Observation final Cholesterol [Mass/volume] in Serum or Plasma 244.93 mg/dL Observation final Triglycerides 128.29 mg/dL Observation final Low Density Lipoprotein Cholesterol 186.76 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 61.609 mg/dL Observation final Glucose [Mass/volume] in Blood 79.56 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 11.9 mg/dL Observation final Creatinine [Mass/volume] in Blood 3.4924 mg/dL Observation final Calcium [Mass/volume] in Blood 8.64 mg/dL Observation final Sodium [Moles/volume] in Blood 141.55 mmol/L Observation final Potassium [Moles/volume] in Blood 3.77 mmol/L Observation final Chloride [Moles/volume] in Blood 103.41 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 25.74 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 85.591 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.3378 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 4.2522 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.3695 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.71031 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 46.135 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 53.457 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 15.795 U/L Observation final Body Height 164.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 4 {score} Observation final Body Weight 95.7 kg Observation final Body mass index (BMI) [Ratio] 35.45 kg/m2 Observation final Blood pressure panel with all children optional 65 mm[Hg] 106 mm[Hg] Observation final Heart rate 95 /min Observation final Respiratory rate 14 /min Observation final Tobacco smoking status Observation final Total score [HARK] 0 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 {score} Observation final Total score [AUDIT-C] 3 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2015-12-18T00:01:30+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2015-12-18 00:01:30+11:00 Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2015-12-18 00:01:30+11:00 Diagnosis Report Humiliation, Afraid, Rape, and Kick questionnaire [HARK] 2015-12-18 00:59:20+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2015-12-18 01:36:46+11:00 Diagnosis Report Alcohol Use Disorder Identification Test - Consumption [AUDIT-C] 2015-12-18 02:11:12+11:00 Diagnosis Report History and physical note 2015-12-18 00:01:30+11:00 Diagnosis Report History and physical note 2016-01-08 00:01:30+11:00 Condition Full-time employment (finding) Condition Limited social contact (finding) Observation final Body Height 164.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 {score} Observation final Body Weight 95.7 kg Observation final Body mass index (BMI) [Ratio] 35.45 kg/m2 Observation final Blood pressure panel with all children optional 66 mm[Hg] 96 mm[Hg] Observation final Heart rate 65 /min Observation final Respiratory rate 15 /min Observation final Tobacco smoking status Observation final Total score [HARK] 0 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2016-12-23T00:01:30+11:00 Immunization completed Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed 2016-12-23T00:01:30+11:00 Diagnosis Report Humiliation, Afraid, Rape, and Kick questionnaire [HARK] 2016-12-23 01:00:23+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2016-12-23 01:43:03+11:00 Diagnosis Report History and physical note 2016-12-23 00:01:30+11:00 Observation final Glucose [Mass/volume] in Blood 78.97 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 14.41 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.9013 mg/dL Observation final Calcium [Mass/volume] in Blood 9.09 mg/dL Observation final Sodium [Moles/volume] in Blood 137.62 mmol/L Observation final Potassium [Moles/volume] in Blood 3.84 mmol/L Observation final Chloride [Moles/volume] in Blood 106.42 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 27.72 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 75.291 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 7.3727 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 4.8053 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 3.3546 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 1.1987 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 41.957 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22.353 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31.903 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 160.83 mg/dL Observation final Triglycerides 192.43 mg/dL Observation final Low Density Lipoprotein Cholesterol 125.83 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 71.838 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2017-01-07 00:01:30+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2017-01-07 00:01:30+11:00 Diagnosis Report History and physical note 2017-01-07 00:01:30+11:00 Condition Social isolation (finding) Condition Stress (finding) Observation final Body Height 164.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 1 {score} Observation final Body Weight 95.7 kg Observation final Body mass index (BMI) [Ratio] 35.45 kg/m2 Observation final Blood pressure panel with all children optional 67 mm[Hg] 105 mm[Hg] Observation final Heart rate 82 /min Observation final Respiratory rate 12 /min Observation final Cholesterol [Mass/volume] in Serum or Plasma 231.94 mg/dL Observation final Triglycerides 135.84 mg/dL Observation final Low Density Lipoprotein Cholesterol 173.7 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 31.08 mg/dL Observation final Leukocytes [#/volume] in Blood by Automated count 5.5433 10*3/uL Observation final Erythrocytes [#/volume] in Blood by Automated count 4.7138 10*6/uL Observation final Hemoglobin [Mass/volume] in Blood 13.425 g/dL Observation final Hematocrit [Volume Fraction] of Blood by Automated count 47.544 % Observation final MCV [Entitic volume] by Automated count 80.306 fL Observation final MCH [Entitic mass] by Automated count 30.358 pg Observation final MCHC [Mass/volume] by Automated count 33.18 g/dL Observation final Erythrocyte distribution width [Entitic volume] by Automated count 41.35 fL Observation final Platelets [#/volume] in Blood by Automated count 441.49 10*3/uL Observation final Platelet distribution width [Entitic volume] in Blood by Automated count 326.23 fL Observation final Platelet mean volume [Entitic volume] in Blood by Automated count 9.6498 fL Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 3 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 2 {score} Observation final Total score [DAST-10] 1 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2017-12-29T00:01:30+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2017-12-29 00:01:30+11:00 Diagnosis Report CBC panel - Blood by Automated count 2017-12-29 00:01:30+11:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2017-12-29 01:20:10+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2017-12-29 02:03:03+11:00 Diagnosis Report Drug Abuse Screening Test-10 [DAST-10] 2017-12-29 02:35:49+11:00 Diagnosis Report History and physical note 2017-12-29 00:01:30+11:00 Observation final Glucose [Mass/volume] in Blood 80.34 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 15.65 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.9692 mg/dL Observation final Calcium [Mass/volume] in Blood 10.1 mg/dL Observation final Sodium [Moles/volume] in Blood 138.68 mmol/L Observation final Potassium [Moles/volume] in Blood 4.5 mmol/L Observation final Chloride [Moles/volume] in Blood 104.56 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 25.15 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 75.753 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 7.5254 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 3.937 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.0612 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 1.1781 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 133.83 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 59.171 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 13.415 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 152.95 mg/dL Observation final Triglycerides 143.51 mg/dL Observation final Low Density Lipoprotein Cholesterol 115.71 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 55.438 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2018-01-07 00:01:30+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2018-01-07 00:01:30+11:00 Diagnosis Report History and physical note 2018-01-07 00:01:30+11:00 Condition Medication review due (situation) Condition Part-time employment (finding) Observation final Body Height 164.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 {score} Observation final Body Weight 95.7 kg Observation final Body mass index (BMI) [Ratio] 35.45 kg/m2 Observation final Blood pressure panel with all children optional 61 mm[Hg] 106 mm[Hg] Observation final Heart rate 94 /min Observation final Respiratory rate 13 /min Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 1 {score} Observation final Total score [HARK] 0 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 2 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2019-01-04T00:01:30+11:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2019-01-04 01:17:59+11:00 Diagnosis Report Humiliation, Afraid, Rape, and Kick questionnaire [HARK] 2019-01-04 01:55:42+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2019-01-04 02:27:55+11:00 Diagnosis Report History and physical note 2019-01-04 00:01:30+11:00 Observation final Glucose [Mass/volume] in Blood 66.5 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 13.63 mg/dL Observation final Creatinine [Mass/volume] in Blood 3.475 mg/dL Observation final Calcium [Mass/volume] in Blood 9.5 mg/dL Observation final Sodium [Moles/volume] in Blood 137.56 mmol/L Observation final Potassium [Moles/volume] in Blood 4.24 mmol/L Observation final Chloride [Moles/volume] in Blood 110.87 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 26.48 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 88.109 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 7.7986 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 3.9073 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.738 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.84168 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 49.401 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 29.093 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 20.575 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 170.23 mg/dL Observation final Triglycerides 131.16 mg/dL Observation final Low Density Lipoprotein Cholesterol 93.965 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 31.988 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2019-01-07 00:01:30+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2019-01-07 00:01:30+11:00 Diagnosis Report History and physical note 2019-01-07 00:01:30+11:00 Condition Full-time employment (finding) Observation final Body Height 164.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 4 {score} Observation final Body Weight 95.7 kg Observation final Body mass index (BMI) [Ratio] 35.45 kg/m2 Observation final Blood pressure panel with all children optional 63 mm[Hg] 114 mm[Hg] Observation final Heart rate 85 /min Observation final Respiratory rate 15 /min Observation final Tobacco smoking status Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 {score} Observation final Total score [DAST-10] 2 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2020-01-10T00:01:30+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2020-01-10 01:36:09+11:00 Diagnosis Report Drug Abuse Screening Test-10 [DAST-10] 2020-01-10 02:12:50+11:00 Diagnosis Report History and physical note 2020-01-10 00:01:30+11:00 Observation final Glucose [Mass/volume] in Blood 65.09 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 12.84 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.7045 mg/dL Observation final Calcium [Mass/volume] in Blood 9.88 mg/dL Observation final Sodium [Moles/volume] in Blood 136.76 mmol/L Observation final Potassium [Moles/volume] in Blood 3.87 mmol/L Observation final Chloride [Moles/volume] in Blood 106.87 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 21.79 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 85.819 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.0673 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 5.3986 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.5273 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.87222 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 126.23 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 29.849 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 25.049 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 207.78 mg/dL Observation final Triglycerides 188.4 mg/dL Observation final Low Density Lipoprotein Cholesterol 127.8 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 36.769 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2020-01-17 00:01:30+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2020-01-17 00:01:30+11:00 Diagnosis Report History and physical note 2020-01-17 00:01:30+11:00 Diagnosis Report History and physical note 2020-10-27 01:52:02+11:00 Condition Medication review due (situation) Condition Suspected COVID-19 Condition Social isolation (finding) Condition Stress (finding) Observation final Body Height 164.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 4 {score} Observation final Body Weight 95.7 kg Observation final Body mass index (BMI) [Ratio] 35.45 kg/m2 Observation final Blood pressure panel with all children optional 57 mm[Hg] 103 mm[Hg] Observation final Heart rate 74 /min Observation final Respiratory rate 13 /min Observation final Cholesterol [Mass/volume] in Serum or Plasma 163.76 mg/dL Observation final Triglycerides 126.71 mg/dL Observation final Low Density Lipoprotein Cholesterol 108.37 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 30.05 mg/dL Observation final Tobacco smoking status Observation final Fall risk total [Morse Fall Scale] 64 {#} Observation final Fall risk level [Morse Fall Scale] Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 {score} Observation final Total score [DAST-10] 1 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2021-01-15T00:01:30+11:00 Immunization completed Pneumococcal conjugate PCV 13 2021-01-15T00:01:30+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2021-01-15 00:01:30+11:00 Diagnosis Report Morse Fall Scale panel 2021-01-15 01:18:24+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2021-01-15 01:58:46+11:00 Diagnosis Report Drug Abuse Screening Test-10 [DAST-10] 2021-01-15 02:37:25+11:00 Diagnosis Report History and physical note 2021-01-15 00:01:30+11:00 Condition Sputum finding (finding) Condition Fatigue (finding) Condition Fever (finding) Condition Loss of taste (finding) Condition COVID-19 Observation final Body temperature 39.015 Cel Observation final Respiratory rate 12.265 /min Observation final Heart rate 94.712 /min Observation final Oxygen saturation in Arterial blood 83.75 % Observation final Blood pressure panel with all children optional 66 mm[Hg] 111 mm[Hg] Observation final Body Weight 95.7 kg Observation final Influenza virus A Ag [Presence] in Upper respiratory specimen by Rapid immunoassay Observation final Influenza virus B Ag [Presence] in Upper respiratory specimen by Rapid immunoassay Observation final SARS-CoV-2 RNA Pnl Resp NAA+probe Diagnosis Report Influenza virus A and B Ag panel - Upper respiratory specimen by Rapid immunoassay 2021-01-19 00:12:29+11:00 Diagnosis Report SARS-CoV-2 RNA Pnl Resp NAA+probe 2021-01-19 01:12:22+11:00 Diagnosis Report History and physical note 2021-01-19 00:01:30+11:00 Observation final Glucose [Mass/volume] in Blood 74.03 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 17.68 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.5707 mg/dL Observation final Calcium [Mass/volume] in Blood 10.16 mg/dL Observation final Sodium [Moles/volume] in Blood 140.54 mmol/L Observation final Potassium [Moles/volume] in Blood 4.97 mmol/L Observation final Chloride [Moles/volume] in Blood 101.75 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 27.07 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 76.781 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.4125 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 3.948 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.5118 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.8094 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 131.07 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 51.35 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22.62 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 187.85 mg/dL Observation final Triglycerides 168.13 mg/dL Observation final Low Density Lipoprotein Cholesterol 130.64 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 77.249 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2021-01-16 00:01:30+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2021-01-16 00:01:30+11:00 Diagnosis Report History and physical note 2021-01-16 00:01:30+11:00 Immunization completed SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose 2021-03-12T00:01:30+11:00 Diagnosis Report History and physical note 2021-03-12 00:01:30+11:00 Immunization completed SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose 2021-04-02T00:01:30+11:00 Diagnosis Report History and physical note 2021-04-02 00:01:30+11:00 Condition Essential hypertension (disorder) Condition Medication review due (situation) Observation final Body Height 164.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 {score} Observation final Body Weight 95.7 kg Observation final Body mass index (BMI) [Ratio] 35.45 kg/m2 Observation final Blood pressure panel with all children optional 99 mm[Hg] 118 mm[Hg] Observation final Heart rate 95 /min Observation final Respiratory rate 14 /min Observation final Tobacco smoking status Observation final Fall risk total [Morse Fall Scale] 6 {#} Observation final Fall risk level [Morse Fall Scale] Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 2 {score} Observation final Total score [AUDIT-C] 2 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2022-01-21T00:01:30+11:00 Immunization completed pneumococcal polysaccharide vaccine, 23 valent 2022-01-21T00:01:30+11:00 Diagnosis Report Morse Fall Scale panel 2022-01-21 01:00:17+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2022-01-21 01:34:20+11:00 Diagnosis Report Alcohol Use Disorder Identification Test - Consumption [AUDIT-C] 2022-01-21 02:16:45+11:00 Diagnosis Report History and physical note 2022-01-21 00:01:30+11:00 Observation final Glucose [Mass/volume] in Blood 71.81 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 12.15 mg/dL Observation final Creatinine [Mass/volume] in Blood 3.1938 mg/dL Observation final Calcium [Mass/volume] in Blood 9.72 mg/dL Observation final Sodium [Moles/volume] in Blood 143.94 mmol/L Observation final Potassium [Moles/volume] in Blood 4.8 mmol/L Observation final Chloride [Moles/volume] in Blood 110.03 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 24.9 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 70.353 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 7.363 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 5.472 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.2899 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.37388 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 97.664 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 40.963 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30.079 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 206.42 mg/dL Observation final Triglycerides 102.77 mg/dL Observation final Low Density Lipoprotein Cholesterol 136.9 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 79.891 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2022-01-28 00:01:30+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2022-01-28 00:01:30+11:00 Diagnosis Report History and physical note 2022-01-28 00:01:30+11:00 Observation final Blood pressure panel with all children optional 90 mm[Hg] 113 mm[Hg] Diagnosis Report History and physical note 2022-02-20 00:01:30+11:00 Observation final Blood pressure panel with all children optional 76 mm[Hg] 94 mm[Hg] Diagnosis Report History and physical note 2022-04-20 23:01:30+10:00 Observation final Blood pressure panel with all children optional 78 mm[Hg] 97 mm[Hg] Diagnosis Report History and physical note 2022-06-19 23:01:30+10:00 Condition Stress (finding) Observation final Body Height 164.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 4 {score} Observation final Body Weight 95.7 kg Observation final Body mass index (BMI) [Ratio] 35.45 kg/m2 Observation final Blood pressure panel with all children optional 67 mm[Hg] 93 mm[Hg] Observation final Heart rate 91 /min Observation final Respiratory rate 14 /min Observation final Leukocytes [#/volume] in Blood by Automated count 7.0993 10*3/uL Observation final Erythrocytes [#/volume] in Blood by Automated count 4.8151 10*6/uL Observation final Hemoglobin [Mass/volume] in Blood 12.369 g/dL Observation final Hematocrit [Volume Fraction] of Blood by Automated count 47.633 % Observation final MCV [Entitic volume] by Automated count 90.75 fL Observation final MCH [Entitic mass] by Automated count 30.628 pg Observation final MCHC [Mass/volume] by Automated count 35.051 g/dL Observation final Erythrocyte distribution width [Entitic volume] by Automated count 39.655 fL Observation final Platelets [#/volume] in Blood by Automated count 410.11 10*3/uL Observation final Platelet distribution width [Entitic volume] in Blood by Automated count 371.38 fL Observation final Platelet mean volume [Entitic volume] in Blood by Automated count 10.318 fL Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 9 {score} Observation final Fall risk total [Morse Fall Scale] 10 {#} Observation final Fall risk level [Morse Fall Scale] Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 {score} Observation final Total score [AUDIT-C] 1 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2023-01-27T00:01:30+11:00 Diagnosis Report CBC panel - Blood by Automated count 2023-01-27 00:01:30+11:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2023-01-27 01:24:27+11:00 Diagnosis Report Morse Fall Scale panel 2023-01-27 01:43:37+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2023-01-27 02:24:08+11:00 Diagnosis Report Alcohol Use Disorder Identification Test - Consumption [AUDIT-C] 2023-01-27 02:57:55+11:00 Diagnosis Report History and physical note 2023-01-27 00:01:30+11:00 Observation final Glucose [Mass/volume] in Blood 94.15 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 16.89 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.8135 mg/dL Observation final Calcium [Mass/volume] in Blood 10.04 mg/dL Observation final Sodium [Moles/volume] in Blood 138.48 mmol/L Observation final Potassium [Moles/volume] in Blood 4.66 mmol/L Observation final Chloride [Moles/volume] in Blood 101.18 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 25.94 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 89.37 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 7.6332 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 3.6602 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 3.0653 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.38984 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 104.52 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 36.165 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 9.3735 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 157.35 mg/dL Observation final Triglycerides 189.73 mg/dL Observation final Low Density Lipoprotein Cholesterol 106.39 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 44.18 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2023-01-28 00:01:30+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2023-01-28 00:01:30+11:00 Diagnosis Report History and physical note 2023-01-28 00:01:30+11:00